Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -185,935 | -124,036 | -58,335 | -221,863 | -155,140 |
| Depreciation Amortization | -1,913 | 3,404 | 1,673 | 6,266 | 5,620 |
| Accounts payable and accrued liabilities | N/A | N/A | -7,750 | N/A | N/A |
| Other Working Capital | -8,070 | -2,126 | -7,470 | 6,076 | 5,906 |
| Other Operating Activity | 30,341 | 14,329 | 14,322 | 31,379 | 21,493 |
| Operating Cash Flow | $-165,577 | $-108,429 | $-57,560 | $-178,142 | $-122,121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,789 | -7,134 | -3,015 | -8,358 | -5,355 |
| Net Acquisitions | N/A | N/A | -7 | 42,726 | N/A |
| Purchase Of Investment | -182,418 | -168,930 | -96,034 | -376,327 | -177,460 |
| Sale Of Investment | 236,982 | 170,585 | 62,335 | 272,894 | 222,074 |
| Other Investing Activity | -36 | -36 | 0 | -261 | 0 |
| Investing Cash Flow | $42,739 | $-5,515 | $-36,721 | $-69,326 | $39,259 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 208,010 | 18,525 | 18,343 | 155,335 | 46,848 |
| Common Stock Repurchased | N/A | N/A | N/A | -47 | N/A |
| Financing Cash Flow | $208,010 | $18,525 | $18,343 | $155,288 | $46,848 |
| Beginning Cash Position | 141,857 | 141,857 | 141,857 | 234,037 | 234,037 |
| End Cash Position | 227,029 | 46,438 | 65,919 | 141,857 | 198,023 |
| Net Cash Flow | $85,172 | $-95,419 | $-75,938 | $-92,180 | $-36,014 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,577 | -108,429 | -57,560 | -178,142 | -122,121 |
| Capital Expenditure | -11,789 | -7,134 | -3,015 | -8,358 | -5,355 |
| Free Cash Flow | -177,366 | -115,563 | -60,575 | -186,500 | -127,476 |